[ad_1]
Medexus Prescribed drugs press launch (OTCQX:MEDXF): This fall Adjusted EBITDA of $4.4 million in fiscal This fall 2024, a lower of $0.4 million, or 8.8%, in comparison with $4.8 million in fiscal This fall 2023.
Adjusted web revenue of $0.8 million for fiscal This fall, 2024.
Income of $26M (-9.1% Y/Y) misses by $0.68M.
Out there liquidity of $5.3 million (March 31, 2024), consisting of money and money equivalents, in comparison with $13.1 million (March 31, 2023).
Money offered by working actions of $18.7 million for fiscal 12 months 2024.
Adjusted web revenue of $0.8 million for fiscal This fall, 2024.
Income of $26M (-9.1% Y/Y) misses by $0.68M.
Out there liquidity of $5.3 million (March 31, 2024), consisting of money and money equivalents, in comparison with $13.1 million (March 31, 2023).
Money offered by working actions of $18.7 million for fiscal 12 months 2024.
Extra on Medexus Prescribed drugs:
[ad_2]
Source link
